tevadaptor - closed drug reconstitution system
teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use
לנלידומיד טבע 10 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 10 mg - lenalidomide
לנלידומיד טבע 15 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 15 mg - lenalidomide
לנלידומיד טבע 2.5 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 2.5 mg - lenalidomide
לנלידומיד טבע 20 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 20 mg - lenalidomide
לנלידומיד טבע 25 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 25 mg - lenalidomide
לנלידומיד טבע 5 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 5 mg - lenalidomide
לנלידומיד טבע 7.5 מג
teva israel ltd - lenalidomide as hydrochloride hydrate - קפסולה קשיחה - lenalidomide as hydrochloride hydrate 7.5 mg - lenalidomide
טבעגרסטים
teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red
טבעקוטן
teva israel ltd - clotrimazole; dexamethasone acetate; neomycin sulfate - קרם - clotrimazole 1 %; dexamethasone acetate 0.044 %; neomycin sulfate 0.645 % - dexamethasone - dexamethasone - tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.